Wei Wang

Wei Wang is currently Chairman at China Mergers & Acquisition Association and Chinese Museum of Finance.
Current roles also include Independent Director at Digital China Information Service Group Co. Ltd. since 2022, Shanghai City Investment Holdings Co. Ltd., Huayuan Real Estate Co. Ltd., Beijing Capital Eco-Environment Protection Group Co., Ltd. since 2024, Meinian Onehealth Healthcare Holdings Co., Ltd. since 2024, and Director at Shanghai Benemae Pharmaceutical Corp.
since 2019.
Dr. Wang is Secretary at Global M&A Research Center.
Former positions include Independent Director at China Sports Industry Group Co., Ltd., China Everbright Group Co., Ltd., Neusoft Corp., Beijing Huayuan Xinhang Holding Co., Ltd., Shanghai Chengtou Holding Co., Ltd., Chongqing Afari Technology Co., Ltd., and China Everbright Bank Co. Ltd. from 2011 to 2014.
Independent Non-Executive Director roles were held at China Huiyuan Juice Group Ltd. from 2015 to 2020, Chong Sing Holdings FinTech Group Ltd. from 2014 to 2017, and Guolian Minsheng Securities Co., Ltd. from 2015 to 2017.
Education includes a doctorate from Fordham University conferred in 1992, undergraduate degrees from PBC School of Finance Tsinghua University and Financial Research Institute in 1985, a graduate degree from China Institute of Finance in 1985, and an undergraduate degree from Dongbei University of Finance & Economics.